ロード中...
Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci
Treatment of severe infections caused by vancomycin-resistant enterococci (VRE) is challenging due to the scarcity of reliable therapeutic alternatives. In this context, daptomycin (DAP), a lipopeptide antibiotic, has emerged as an interesting alternative as it is one of the few compounds that retai...
保存先:
| 出版年: | Int J Antimicrob Agents |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4417356/ https://ncbi.nlm.nih.gov/pubmed/25261158 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijantimicag.2014.08.002 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|